Authors: COASTSENIOR EA KRONER BA KELLEY CL TRILLI LE

Citation: Ea. Coastsenior et al., MANAGEMENT OF PATIENTS WITH TYPE-2 DIABETES BY PHARMACISTS IN PRIMARY-CARE CLINICS, The Annals of pharmacotherapy, 32(6), 1998, pp. 636-641

Authors: TRILLI LE KELLEY CL ASPINALL SL KRONER BA

Citation: Le. Trilli et al., POTENTIAL INTERACTION BETWEEN WARFARIN AND FLUVASTATIN, The Annals of pharmacotherapy, 30(12), 1996, pp. 1399-1402

Authors: HASELBERGER MB KRONER BA

Citation: Mb. Haselberger et Ba. Kroner, DRUG POISONING IN OLDER PATIENTS - PREVENTATIVE AND MANAGEMENT STRATEGIES, Drugs & aging, 7(4), 1995, pp. 292-297

Authors: KRONER BA KELLEY CL BARANOWSKI EM

Citation: Ba. Kroner et al., LABELING DEFICIENCIES AND COMMUNICATION PROBLEMS LEADING TO MEDICATION MISUSE IN THE ELDERLY, Drugs & aging, 5(6), 1994, pp. 403-410

Authors: KRONER BA MULLIGAN T BRIGGS GC

Citation: Ba. Kroner et al., EFFECT OF FREQUENTLY PRESCRIBED CARDIOVASCULAR MEDICATIONS ON SEXUAL FUNCTION - A PILOT-STUDY, The Annals of pharmacotherapy, 27(11), 1993, pp. 1329-1332

Authors: KRONER BA SCOTT RB WARING ER ZANGA JR

Citation: Ba. Kroner et al., POISONING IN THE ELDERLY - CHARACTERIZATION OF EXPOSURES REPORTED TO A POISON CONTROL CENTER, Journal of the American Geriatrics Society, 41(8), 1993, pp. 842-846